These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 23597193)
41. OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy. Zheng N; Yang P; Wang Z; Zhou Q Curr Cancer Drug Targets; 2017; 17(1):40-47. PubMed ID: 26881930 [TBL] [Abstract][Full Text] [Related]
42. MicroRNAs and cancer: towards a personalized medicine. Fabbri M Curr Mol Med; 2013 Jun; 13(5):751-6. PubMed ID: 23642056 [TBL] [Abstract][Full Text] [Related]
43. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma. Gailhouste L; Ochiya T Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781 [TBL] [Abstract][Full Text] [Related]
44. MicroRNAs in Anticancer Drugs Hepatotoxicity: From Pathogenic Mechanism and Early Diagnosis to Therapeutic Targeting by Natural Products. Atteia HH Curr Pharm Biotechnol; 2024; 25(14):1791-1806. PubMed ID: 38178678 [TBL] [Abstract][Full Text] [Related]
45. Tumor-Progressive Mechanisms Mediating miRNA-Protein Interaction. Konishi H; Sato H; Takahashi K; Fujiya M Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830186 [TBL] [Abstract][Full Text] [Related]
46. Small non-coding RNAs as novel therapeutics. Rossbach M Curr Mol Med; 2010 Jun; 10(4):361-8. PubMed ID: 20455856 [TBL] [Abstract][Full Text] [Related]
47. Emerging roles for modulation of microRNA signatures in cancer chemoprevention. Neelakandan K; Babu P; Nair S Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522 [TBL] [Abstract][Full Text] [Related]
48. MicroRNAs involved with hepatocellular carcinoma (Review). Mao B; Wang G Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882 [TBL] [Abstract][Full Text] [Related]
49. [The Role of MicroRNAs in Colorectal Cancer]. Kim SW Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421 [TBL] [Abstract][Full Text] [Related]
50. Regulatory Roles of Non-Coding RNAs in Colorectal Cancer. Wang J; Song YX; Ma B; Wang JJ; Sun JX; Chen XW; Zhao JH; Yang YC; Wang ZN Int J Mol Sci; 2015 Aug; 16(8):19886-919. PubMed ID: 26307974 [TBL] [Abstract][Full Text] [Related]
52. Bone Metastasis-Related MicroRNAs: New Targets for Treatment? Zhao Q; Luo F; Ma J; Yu X Curr Cancer Drug Targets; 2015; 15(8):716-25. PubMed ID: 26119014 [TBL] [Abstract][Full Text] [Related]
54. miR221/222 in cancer: their role in tumor progression and response to therapy. Garofalo M; Quintavalle C; Romano G; Croce CM; Condorelli G Curr Mol Med; 2012 Jan; 12(1):27-33. PubMed ID: 22082479 [TBL] [Abstract][Full Text] [Related]
55. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266 [TBL] [Abstract][Full Text] [Related]
56. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential. Asiaf A; Ahmad ST; Arjumand W; Zargar MA Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366 [TBL] [Abstract][Full Text] [Related]
57. microRNAs in cancer management. Kong YW; Ferland-McCollough D; Jackson TJ; Bushell M Lancet Oncol; 2012 Jun; 13(6):e249-58. PubMed ID: 22652233 [TBL] [Abstract][Full Text] [Related]
58. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers. Jing Z; Han W; Sui X; Xie J; Pan H Cancer Lett; 2015 Jan; 356(2 Pt B):332-8. PubMed ID: 25304373 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA-224: as a potential target for miR-based therapy of cancer. Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100 [TBL] [Abstract][Full Text] [Related]